Sciterion wins 2015 Communique Award for excellence in meetings
19th October 2015
Therapies in Musculoskeletal Disease
Advancing Regenerative Therapies in Musculoskeletal Disease
9th June 2016
Show all

Regulating a Damage Repair Approach to Cure the Diseases of Aging – Panel Discussion

Biological Innovation

August 23, 2014, 12:30pm

Escalating societal healthcare needs have driven an unprecedented era of biomedical innovation. However, the development of candidate technologies without consideration of a robust regulatory strategy is likely to contribute to stymied patient access and commercial viability. Therefore, this session considered worldwide efforts to rapidly and proportionally develop international regulatory processes to accommodate increasingly heterogeneous and unfamiliar healthcare technologies and their swift translation from lab to bedside.


David Brindley, Research Fellow, University of Oxford/Centre for the Advancement of Sustainable Medical Innovation (Moderator)
Bob Clay, Chief Regulatory Officer, Kinapse & Managing Director, Highbury Regulatory Science
Andrew Martello, Managing Director, Spoonful of Sugar
Evan Snyder, Director, Centre for Stem Cell and Regenerative Medicine, Director, Stem Cell Research Centre and Core Facility, Sanford-Burnham Medical Research Institute